Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIRAPARIB Cause Intentional product misuse? 120 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Intentional product misuse have been filed in association with NIRAPARIB (ZEJULA). This represents 0.6% of all adverse event reports for NIRAPARIB.

120
Reports of Intentional product misuse with NIRAPARIB
0.6%
of all NIRAPARIB reports
2
Deaths
25
Hospitalizations

How Dangerous Is Intentional product misuse From NIRAPARIB?

Of the 120 reports, 2 (1.7%) resulted in death, 25 (20.8%) required hospitalization, and 10 (8.3%) were considered life-threatening.

Is Intentional product misuse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 120 reports have been filed with the FAERS database.

What Other Side Effects Does NIRAPARIB Cause?

Nausea (5,794) Fatigue (5,240) Constipation (4,128) Platelet count decreased (4,102) Insomnia (2,861) Blood pressure increased (2,464) Headache (2,383) Off label use (2,213) Vomiting (2,029) Carbohydrate antigen 125 increased (1,868)

What Other Drugs Cause Intentional product misuse?

ETANERCEPT (3,992) PREGABALIN (3,731) BUDESONIDE\FORMOTEROL (3,399) ACETAMINOPHEN (2,924) ESOMEPRAZOLE (2,852) MINOXIDIL (2,418) TOFACITINIB (2,331) CINACALCET (2,092) QUETIAPINE (1,855) ALPRAZOLAM (1,709)

Which NIRAPARIB Alternatives Have Lower Intentional product misuse Risk?

NIRAPARIB vs NIRMATRELVIR\RITONAVIR NIRAPARIB vs NIROGACESTAT NIRAPARIB vs NIROGACESTAT HYDROBROMIDE NIRAPARIB vs NIRSEVIMAB NIRAPARIB vs NIRSEVIMAB-ALIP

Related Pages

NIRAPARIB Full Profile All Intentional product misuse Reports All Drugs Causing Intentional product misuse NIRAPARIB Demographics